Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinomaGloria Peiró(Ludwig-Maximilians-Universität München), Enrique Lerma(Hospital de Sant Pau)British Journal of CancerJune 17, 201410.1038/bjc.2014.327Cited by 94SaveCiteExport RISWatch citationsRelated PapersAnalysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome|Modern Pathology|2004|60High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype|Research Square|2024|1